Astellas To Pay $7M To End Mycamine FCA Suit
The deal resolves allegations that between 2005 and 2010, Astellas — the U.S. unit of a Japanese drugmaker — knowingly promoted Mycamine for pediatric use, without approval from the U.S. Food and...
Other Statutes: Other Statutory Actions
March 7, 2010
Follow our exclusive coverage of the trial of the year:Catch up on the Dewey trial here